Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CYTEK BIOSCIENCES, INC.

(CTKB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/20/2022 01/21/2022 01/24/2022 01/25/2022 01/26/2022 Date
14.13(c) 14.22(c) 14.83(c) 14.01(c) 13.97 Last
483 654 438 713 387 442 255 767 399 102 Volume
+1.15% +0.64% +4.29% -5.53% -0.29% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 125 M - -
Net income 2021 5,70 M - -
Net cash position 2021 395 M - -
P/E ratio 2021 140x
Yield 2021 -
Sales 2022 160 M - -
Net income 2022 1,00 M - -
Net cash position 2022 404 M - -
P/E ratio 2022 1 397x
Yield 2022 -
Capitalization 1 868 M 1 868 M -
EV / Sales 2021 11,7x
EV / Sales 2022 9,13x
Nbr of Employees 462
Free-Float -
More Financials
Company
Cytek Biosciences, Inc is a cell analysis solutions company. The Company offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells Full Spectrum Profiling (FSP). Its FSP... 
More about the company
All news about CYTEK BIOSCIENCES, INC.
01/19Certain Common Stock of Cytek Biosciences, Inc. are subject to a Lock-Up Agreement Endi..
CI
01/19Certain Stock Options of Cytek Biosciences, Inc. are subject to a Lock-Up Agreement End..
CI
01/06CYTEK BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
01/06Cytek Biosciences, Inc. Appoints Vera Imper as A Class II Director
CI
01/05Cytek« Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
GL
01/05Cytek« Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
GL
01/05Cytek« Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
CI
2021CYTEK BIOSCIENCES, INC.(NASDAQGS : CTKB) added to S&P Global BMI Index
CI
2021Cytek« Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis Sy..
GL
2021Cytek? Biosciences Marks Milestone Achievement with Shipment of 1,000th Cell Analysis S..
CI
2021CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
2021Cytek Biosciences Reports Third Quarter 2021 Financial Results - Form 8-K
PU
2021Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q3 Revenue $34.4M, vs. Street Est of $33...
MT
2021Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q3 EPS $0.02, vs. Street Est of $0.02
MT
2021Cytek Biosciences Reports Third Quarter 2021 Financial Results
AQ
More news
News in other languages on CYTEK BIOSCIENCES, INC.
01/06Cytek Biosciences, Inc. nomme Vera Imper comme directrice de classe II
01/05Cytek« Biosciences agrandit son siège de Fremont et triple sa capacité de production
2021Earnings Flash (CTKB) CYTEK BIOSCIENCES affiche un chiffre d'affaires de 34,4 millions ..
2021Cytek Biosciences acquiert l'unité d'analyse cellulaire de Tonbo Biosciences pour une s..
2021Baisse du bénéfice net de Cytek Biosciences au deuxième trimestre, hausse du chiffre d'..
More news
Analyst Recommendations on CYTEK BIOSCIENCES, INC.
More recommendations
Chart CYTEK BIOSCIENCES, INC.
Duration : Period :
Cytek Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CYTEK BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 13,97 $
Average target price 25,00 $
Spread / Average Target 79,0%
EPS Revisions
Managers and Directors
Wen Bin Jiang President, Chief Executive Officer & Director
Patrik Sebastian Jeanmonod Chief Financial Officer
Ming Yan Director & Chief Technology Officer
Jack T. Ball Independent Director
Therese Cameron Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CYTEK BIOSCIENCES, INC.-14.40%1 873
THERMO FISHER SCIENTIFIC-14.91%223 721
DANAHER CORPORATION-18.92%193 793
INTUITIVE SURGICAL, INC.-26.40%94 361
SIEMENS HEALTHINEERS AG-11.61%73 251
EDWARDS LIFESCIENCES CORPORATION-16.15%68 358